Design Methods for Antimicrobial Peptides with Improved Performance DOI Open Access
James Mwangi, Peter Muiruri Kamau,

Rebecca Caroline Thuku

и другие.

动物学研究, Год журнала: 2023, Номер 0(0), С. 0 - 0

Опубликована: Янв. 1, 2023

The Recalcitrance of pathogens to traditional antibiotics has made treating and eradicating bacterial infections more difficult. In this regard, developing new antimicrobial agents combat antibiotic-resistant strains become a top priority. Antimicrobial peptides (AMPs), ubiquitous class naturally occurring compounds with broad-spectrum anti-pathogen activity, hold significant promise as one the most effective solutions current resistance (AMR) crisis. Several AMPs have been identified evaluated for their therapeutic application, many already in drug development pipeline. Their distinct properties, such high target specificity, potency, ability bypass microbial mechanisms, make them promising alternative antibiotics. Nonetheless, several challenges, toxicity, lability proteolytic degradation, low stability, poor pharmacokinetics, production costs, continue hamper clinical applicability. Therefore, much recent research focused on optimizing peptides' properties improve performance. By understanding physiochemical AMPs, amphipathicity, hydrophobicity, structural conformation, amino acid distribution, composition, that correspond researchers can design desired improved review, we highlight some key strategies, rational de novo design, used optimize performance AMPs. We also discuss how evolution predictive computational tools technologies utilize artificial intelligence machine learning are increasingly being synthesize lead candidates efficacy.

Язык: Английский

Recent advances in design of antimicrobial peptides and polypeptides toward clinical translation DOI Creative Commons
Yunjiang Jiang, Yingying Chen, Ziyuan Song

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2021, Номер 170, С. 261 - 280

Опубликована: Янв. 2, 2021

Язык: Английский

Процитировано

197

Structure–activity relationship of cationic surfactants as antimicrobial agents DOI
Chengcheng Zhou, Yilin Wang

Current Opinion in Colloid & Interface Science, Год журнала: 2019, Номер 45, С. 28 - 43

Опубликована: Дек. 6, 2019

Язык: Английский

Процитировано

186

Synthetic antimicrobial peptides: Characteristics, design, and potential as alternative molecules to overcome microbial resistance DOI Creative Commons

Patrícia G. Lima,

José T.A. Oliveira, Jackson L. Amaral

и другие.

Life Sciences, Год журнала: 2021, Номер 278, С. 119647 - 119647

Опубликована: Май 24, 2021

Язык: Английский

Процитировано

123

Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance DOI Creative Commons

Geetika Dhanda,

Yash Acharya, Jayanta Haldar

и другие.

ACS Omega, Год журнала: 2023, Номер 8(12), С. 10757 - 10783

Опубликована: Март 14, 2023

The problem of antibiotic resistance is on the rise, with multidrug-resistant strains emerging even to last resort antibiotics. drug discovery process often stalled by stringent cut-offs required for effective design. In such a scenario, it prudent delve into varying mechanisms existing antibiotics and target them improve efficacy. Nonantibiotic compounds called adjuvants which bacterial can be used in combination obsolete drugs an improved therapeutic regime. field "antibiotic adjuvants" has gained significant traction recent years where other than β-lactamase inhibition have been explored. This review discusses multitude acquired inherent employed bacteria resist action. major focus this how these use adjuvants. Different types direct acting indirect breakers are discussed including enzyme inhibitors, efflux pump inhibitors teichoic acid synthesis, cellular processes. multifaceted class membrane-targeting poly pharmacological effects potential host immune-modulating also reviewed. We conclude providing insights about challenges preventing clinical translation different classes adjuvants, especially membrane-perturbing compounds, framework possible directions pursued fill gap. Antibiotic–adjuvant combinatorial therapy indeed immense as upcoming orthogonal strategy conventional discovery.

Язык: Английский

Процитировано

91

Intrinsic antimicrobial resistance: Molecular biomaterials to combat microbial biofilms and bacterial persisters DOI
Swagatam Barman,

Leman Buzoglu Kurnaz,

Ryan Leighton

и другие.

Biomaterials, Год журнала: 2024, Номер 311, С. 122690 - 122690

Опубликована: Июнь 28, 2024

Язык: Английский

Процитировано

27

6,7-Coumarin-heterocyclic hybrids: A comprehensive review of their natural sources, synthetic approaches, and bioactivity DOI
Nameer Mazin Zeki, Yasser Fakri Mustafa

Journal of Molecular Structure, Год журнала: 2024, Номер 1303, С. 137601 - 137601

Опубликована: Янв. 22, 2024

Язык: Английский

Процитировано

23

Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides in the Modern Era: An Updated Review DOI Creative Commons

Layla Tajer,

Jean‐Christophe Paillart, Hanna Dib

и другие.

Microorganisms, Год журнала: 2024, Номер 12(7), С. 1259 - 1259

Опубликована: Июнь 21, 2024

Antimicrobial resistance (AMR) poses a serious global health concern, resulting in significant number of deaths annually due to infections that are resistant treatment. Amidst this crisis, antimicrobial peptides (AMPs) have emerged as promising alternatives conventional antibiotics (ATBs). These cationic peptides, naturally produced by all kingdoms life, play crucial role the innate immune system multicellular organisms and bacterial interspecies competition exhibiting broad-spectrum activity against bacteria, fungi, viruses, parasites. AMPs target pathogens through multiple mechanisms, most importantly disrupting their membranes, leading cell lysis. However, host has slow co-evolutionary process between microorganisms hosts. Alarmingly, development last-resort treatment MDR infections, such colistin, is attributed misuse peptide high rate horizontal genetic transfer corresponding genes. AMP-resistant bacteria employ diverse including but not limited proteolytic degradation, extracellular trapping inactivation, active efflux, well complex modifications wall membrane structures. This review comprehensively examines constitutive inducible molecular mechanisms supported experimental evidence described date pathogens. We also explore specificity these toward structurally broaden enhance potential developing applying them therapeutics for bacteria. Additionally, we provide insights into significance AMP within context host-pathogen interactions.

Язык: Английский

Процитировано

21

Design and Application of Antimicrobial Peptide Conjugates DOI Open Access

André Reinhardt,

Ines Neundorf

International Journal of Molecular Sciences, Год журнала: 2016, Номер 17(5), С. 701 - 701

Опубликована: Май 11, 2016

Antimicrobial peptides (AMPs) are an interesting class of antibiotics characterized by their unique antibiotic activity and lower propensity for developing resistance compared to common antibiotics. They belong the membrane-active usually act selectively against bacteria, fungi protozoans. AMPs, but also peptide conjugates containing have come more into focus research during last few years. Within this article, recent work on AMP is reviewed. Different aspects will be highlighted as a combination AMPs with or organometallic compounds aiming increase antibacterial target selectivity, conjugation photosensitizers improving photodynamic therapy (PDT) attachment particles, name only few. Owing enormous resonance antimicrobial in literature so far, topic seems very attractive different scientific fields, like medicine, biology, biochemistry chemistry.

Язык: Английский

Процитировано

136

More Than a Pore: A Current Perspective on the In Vivo Mode of Action of the Lipopeptide Antibiotic Daptomycin DOI Creative Commons

Declan A. Gray,

Michaela Wenzel

Antibiotics, Год журнала: 2020, Номер 9(1), С. 17 - 17

Опубликована: Янв. 3, 2020

Daptomycin is a cyclic lipopeptide antibiotic, which was discovered in 1987 and entered the market 2003. To date, it serves as last resort antibiotic to treat complicated skin infections, bacteremia, right-sided endocarditis caused by Gram-positive pathogens, most prominently methicillin-resistant Staphylococcus aureus. representative of novel class that introduced clinic. It also one few membrane-active compounds can be applied systemically. While antibiotics have long been limited topical applications were generally excluded from systemic drug development, they promise slower resistance development than many classical drugs target single proteins. The success daptomycin together with emergence more multi-resistant superbugs attracted renewed interest this compound class. Studying pioneering might help pave way for future membrane-targeting antibiotics. However, 30 years after its discovery, exact mechanism action still debated. In particular, there prominent discrepancy between vivo vitro studies. review, we discuss current knowledge on against bacteria try offer explanations these conflicting observations.

Язык: Английский

Процитировано

99

Natural and Synthetic Peptides with Antifungal Activity DOI
Tecla Ciociola, Laura Giovati, Stefania Conti

и другие.

Future Medicinal Chemistry, Год журнала: 2016, Номер 8(12), С. 1413 - 1433

Опубликована: Авг. 1, 2016

In recent years, the increase of invasive fungal infections and emergence antifungal resistance stressed need for new drugs. Peptides have shown to be good candidates development alternative antimicrobial agents through high-throughput screening, subsequent optimization according a rational approach. This review presents brief overview on natural peptides different sources (animals, plants, micro-organisms), peptide fragments derived by proteolytic cleavage precursor physiological proteins (cryptides), synthetic unnatural derivatives. Antifungal are schematically reported based their structure, spectrum effects. Natural or modified derivatives may represent basis compounds active against infections.

Язык: Английский

Процитировано

90